CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

赫力昂与新加坡科技研究局启动亚洲女性代谢健康新临床研究

Trial StartCentrumPositive
AI Analysis

Summary

Haleon and Singapore's A*STAR have launched a new clinical study examining the metabolic health benefits of Centrum multivitamin and mineral supplement in middle-aged Asian women, addressing an understudied population in global nutrition research.

Clinical Trial Data

Importance:4/10
Sentiment:
0.30
clinical trialmetabolic healthwomen's healthAsia-Pacificdietary supplementresearch collaboration

Read the original article

Published by PR Newswire Clinical Trials on August 14, 2026 5:49 AM

Read Original